GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siegfried Holding AG (CHIX:SFZNz) » Definitions » EPS (Diluted)

Siegfried Holding AG (CHIX:SFZNZ) EPS (Diluted) : CHF29.81 (TTM As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Siegfried Holding AG EPS (Diluted)?

Siegfried Holding AG's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was CHF16.58. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was CHF29.81.

Siegfried Holding AG's EPS (Basic) for the six months ended in Jun. 2024 was CHF16.73. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was CHF30.19.

Siegfried Holding AG's EPS without NRI for the six months ended in Jun. 2024 was CHF16.67. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was CHF32.63.

During the past 12 months, Siegfried Holding AG's average EPS without NRIGrowth Rate was 15.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 20.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 20.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Siegfried Holding AG's highest 3-Year average EPS without NRI Growth Rate was 453.80% per year. The lowest was -78.80% per year. And the median was 19.20% per year.


Siegfried Holding AG EPS (Diluted) Historical Data

The historical data trend for Siegfried Holding AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siegfried Holding AG EPS (Diluted) Chart

Siegfried Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.53 14.18 22.03 36.28 26.22

Siegfried Holding AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.51 21.77 12.99 13.23 16.58

Competitive Comparison of Siegfried Holding AG's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siegfried Holding AG's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Siegfried Holding AG's PE Ratio falls into.



Siegfried Holding AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Siegfried Holding AG's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(112.774-0)/4.300
=26.23

Siegfried Holding AG's Diluted EPS for the quarter that ended in Jun. 2024 is calculated as

Diluted EPS (Q: Jun. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(71.383-0)/4.305
=16.58

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF29.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Siegfried Holding AG  (CHIX:SFZNz) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Siegfried Holding AG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Siegfried Holding AG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Siegfried Holding AG Business Description

Traded in Other Exchanges
Address
Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried Holding is a global contract development and manufacturing organization, or CDMO. Siegfried derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. Siegfried provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 12 production sites on three continents.

Siegfried Holding AG Headlines

No Headlines